Identification of evolutionary mechanisms of myelomatous effusion by single-cell RNA sequencing

被引:10
作者
Sun, Zhengxu [1 ]
Ji, Jiamei [1 ]
Li, Yating [1 ]
Cui, Yunqi [1 ]
Fan, Lei [1 ]
Li, Jianyong [1 ]
Qu, Xiaoyan [1 ]
机构
[1] Nanjing Med Univ, Jiangsu Prov Hosp, Dept Hematol, Affiliated Hosp 1, 300 Guangzhou Rd, Nanjing 210029, Peoples R China
基金
中国国家自然科学基金;
关键词
PLEURAL EFFUSION; MULTIPLE-MYELOMA; EXTRAMEDULLARY DISEASE; TUMOR HETEROGENEITY; ASCITES;
D O I
10.1182/bloodadvances.2022009477
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myelomatous effusion (ME) is a rare manifestation of extramedullary multiple myeloma (MM) with limited therapeutic options and poor outcomes. The molecular mechanisms underlying ME are incompletely understood. We profiled transcriptomes of bone marrow, peripheral blood (PB), and pleural effusion/ascites from 3 patients with ME using single-cell RNA sequencing analysis. We found that ME contained a higher percentage of cytotoxic T cells, whereas PB contained a higher proportion of naive T cells. Malignant cells varied within and between sites and patients in their expression of signatures. We identified a gene module highly expressed in intramedullary and extramedullary plasma cell clusters and defined cell clusters expressing this gene set as extramedullary-initiating cells (EMICs). This gene set was associated with increased cellular proliferation, involved in p53 signaling, and related to poor prognosis in MM. The transcriptional regulators E2F1, YY1, and SMAD1 were activated in EMICs. Leukocyte immunoglobulin-like receptor subfamily B4 (LILRB4) was upregulated in extramedullary EMICs. We confirmed that LILRB4 promoted MM cell migration in vitro. This study provided insight into the evolutionary mechanisms of ME and defined EMICs and LILRB4 associated with extramedullary development.
引用
收藏
页码:4148 / 4159
页数:12
相关论文
共 54 条
  • [1] Concise Review: Defining and Targeting Myeloma Stem Cell-Like Cells
    Abe, Masahiro
    Harada, Takeshi
    Matsumoto, Toshio
    [J]. STEM CELLS, 2014, 32 (05) : 1067 - 1073
  • [2] UCell: Robust and scalable single-cell gene signature scoring
    Andreatta, Massimo
    Carmona, Santiago J.
    [J]. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 3796 - 3798
  • [3] A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome
    Beksac, Meral
    Seval, Guldane Cengiz
    Kanellias, Nicholas
    Coriu, Daniel
    Rosinol, Laura
    Ozet, Gulsum
    Goranova-Marinova, Vesselina
    Unal, Ali
    Bila, Jelena
    Ozsan, Hayri
    Ivanaj, Arben
    Balic, Lejla Ibricevic
    Kastritis, Efstathios
    Blade, Joan
    Dimopoulos, Meletios Athanasios
    [J]. HAEMATOLOGICA, 2020, 105 (01) : 201 - 208
  • [4] Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma
    Bergsagel, PL
    Kuehl, WM
    Zhan, FH
    Sawyer, J
    Barlogie, B
    Shaughnessy, J
    [J]. BLOOD, 2005, 106 (01) : 296 - 303
  • [5] Extramedullary multiple myeloma
    Bhutani, Manisha
    Foureau, David M.
    Atrash, Shebli
    Voorhees, Peter M.
    Usmani, Saad Z.
    [J]. LEUKEMIA, 2020, 34 (01) : 1 - 20
  • [6] Pleural Effusion in Multiple Myeloma: Characteristics and Practice Patterns
    Byun, Ja Min
    Kim, Ki Hwan
    Choi, In Sil
    Park, Jin Hyun
    Kim, Jin-Soo
    Shin, Dong-Yeop
    Koh, Youngil
    Kim, Inho
    Yoon, Sung-Soo
    Lim, Hyo Jeong
    [J]. ACTA HAEMATOLOGICA, 2017, 138 (02) : 69 - 76
  • [7] METTL3 facilitates multiple myeloma tumorigenesis by enhancing YY1 stability and pri-microRNA-27 maturation in m6A-dependent manner
    Che, Feifei
    Ye, Xuemei
    Wang, Yu
    Wang, Xuemei
    Ma, Shuyue
    Tan, Yawen
    Mao, Yan
    Luo, Ziyue
    [J]. CELL BIOLOGY AND TOXICOLOGY, 2023, 39 (05) : 2033 - 2050
  • [8] Tumour heterogeneity and resistance to cancer therapies
    Dagogo-Jack, Ibiayi
    Shaw, Alice T.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (02) : 81 - 94
  • [9] Efficacy of Humanized Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With and Without Extramedullary Disease
    Deng, Haobin
    Liu, Meijing
    Yuan, Ting
    Zhang, Huan
    Cui, Rui
    Li, Jingyi
    Yuan, Jijun
    Wang, Xiaofang
    Wang, Yafei
    Deng, Qi
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [10] LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration
    Deng, Mi
    Gui, Xun
    Kim, Jaehyup
    Xie, Li
    Chen, Weina
    Li, Zunling
    He, Licai
    Chen, Yuanzhi
    Chen, Heyu
    Luo, Weiguang
    Lu, Zhigang
    Xie, Jingjing
    Churchill, Hywyn
    Xu, Yixiang
    Zhou, Zhan
    Wu, Guojin
    Yu, Chenyi
    John, Samuel
    Hirayasu, Kouyuki
    Nam Nguyen
    Liu, Xiaoye
    Huang, Fangfang
    Li, Leike
    Deng, Hui
    Tang, Haidong
    Sadek, Ali H.
    Zhang, Lingbo
    Huang, Tao
    Zou, Yizhou
    Chen, Benjamin
    Zhu, Hong
    Arase, Hisashi
    Xia, Ningshao
    Jiang, Youxing
    Collins, Robert
    You, M. James
    Homsi, Jade
    Unni, Nisha
    Lewis, Cheryl
    Chen, Guo-Qiang
    Fu, Yang-Xin
    Liao, X. Charlene
    An, Zhiqiang
    Zheng, Junke
    Zhang, Ningyan
    Zhang, Cheng Cheng
    [J]. NATURE, 2018, 562 (7728) : 605 - +